Journal article
Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity
- Abstract:
- Elevated levels of brain natriuretic peptide (BNP) are regarded as an early compensatory response to cardiac myocyte hypertrophy, although exogenously administered BNP shows poor clinical efficacy in heart failure and hypertension. We tested whether phosphodiesterase 2A (PDE2A), which regulates the action of BNP-activated cyclic guanosine monophosphate (cGMP), was directly involved in modulating Ca2+ handling from stellate ganglia (SG) neurons and cardiac norepinephrine (NE) release in rats and humans with an enhanced sympathetic phenotype. SG were also isolated from patients with sympathetic hyperactivity and healthy donor patients. PDE2A activity of the SG was greater in both spontaneously hypertensive rats (SHRs) and patients compared with their respective controls, whereas PDE2A mRNA was only high in SHR SG. BNP significantly reduced the magnitude of the calcium transients and ICaN in normal Wistar Kyoto (WKY) SG neurons, but not in the SHRs. cGMP levels stimulated by BNP were also attenuated in SHR SG neurons. Overexpression of PDE2A in WKY neurons recapitulated the calcium phenotype seen in SHR neurons. Functionally, BNP significantly reduced [3H]-NE release in the WKY rats, but not in the SHRs. Blockade of overexpressed PDE2A with Bay 60-7550 or overexpression of catalytically inactive PDE2A reestablished the modulatory action of BNP in SHR SG neurons. This suggests that PDE2A may be a key target in modulating the action of BNP to reduce sympathetic hyperactivity.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 1018.7KB, Terms of use)
-
- Publisher copy:
- 10.1172/jci.insight.98694
Authors
- Publisher:
- American Society for Clinical Investigation
- Journal:
- JCI insight More from this journal
- Volume:
- 3
- Issue:
- 9
- Pages:
- e98694
- Publication date:
- 2018-05-03
- Acceptance date:
- 2018-04-05
- DOI:
- ISSN:
-
2379-3708
- Pmid:
-
29720569
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:846111
- UUID:
-
uuid:bd4da0a7-ebc3-47ab-b6cf-8efdc8a2f29b
- Local pid:
-
pubs:846111
- Source identifiers:
-
846111
- Deposit date:
-
2018-05-09
Terms of use
- Copyright holder:
- American Society for Clinical Investigation
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 American Society for Clinical Investigation. This is the accepted manuscript version of the article. The final version is available online from the American Society for Clinical Investigation at: http://dx.doi.org/10.1172/jci.insight.98694
If you are the owner of this record, you can report an update to it here: Report update to this record